The largest database of trusted experimental protocols

Blocking solution

Manufactured by Thermo Fisher Scientific
Sourced in United States

Blocking solution is a laboratory reagent used to prevent non-specific binding in immunoassays and other protein detection techniques. It is designed to block unoccupied binding sites on the solid support or membrane to reduce background signals and improve the specificity of the target analyte detection.

Automatically generated - may contain errors

54 protocols using blocking solution

1

Immunofluorescence and Electron Microscopy of rSVA-eGFP Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
BSR cells were infected (MOI = 1) with the rSVA-eGFP for 12 h, and then fixed in 4% paraformaldehyde at room temperature for 30 min. After fixation, cells were washed four times with PBS, and then permeated with 0.4% Triton X-100 at room temperature for 30 min. After permeation, cells were washed three times with PBS and blocked in blocking solution (Takara, Dalian, China) at 37 °C for 1 h. Subsequently, cells were incubated with the anti-VP1 monoclonal antibody (MAb, 1: 400 in blocking solution) at 37 °C for 2 h. After incubation with the primary antibody, cells were washed three times with PBS and incubated with the Alexa Fluor® 555 conjugate (Thermo Fisher, Waltham, MA, USA) (1: 250 in blocking solution) at 37 °C for 1 h. Cells were washed three times with PBS, coated with 90% glycerin, and visualized under the fluorescence microscope.
BSR cells were infected (MOI = 1) with the rSVA-eGFP for 12 h, and then collected to prepare ultrathin section for transmission electron microscope (TEM) observation at the Wuhan Servicebio Technology Co., Ltd. (Wuhan, China).
+ Open protocol
+ Expand
2

Immunofluorescence Analysis of NF-κB, TLR2, and TLR4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neutrophil elastase-treated macrophages stimulated with HK-Spn or LPS were fixed and permeabilized using a cell fixation and permeabilization kit (Thermo Fisher Scientific) according to manufacturer instructions, followed by incubation of the cells in a blocking solution (Thermo Fisher Scientific) for 30 min. Samples were stained with rabbit anti-NF-κB p65 antibody (Santa Cruz Biotechnology, Dallas, TX, USA), anti-toll-like receptor (TLR) 2 antibody (clone TL2.1; Thermo Fisher Scientific), or anti-TLR4 antibody (clone HTA125; Thermo Fisher Scientific) in blocking solution. After overnight incubation at 4°C, secondary AlexaFluor 594-conjugated goat anti-rabbit IgG antibody or AlexaFluor 488-conjugated goat anti-mouse IgG antibody (Thermo Fisher Scientific) in blocking buffer was added, followed by a 2-h incubation in the dark. Then, samples were observed using a confocal laser-scanning microscope (Carl Zeiss, Jena, Germany). In addition, samples were observed with fluorescence microscopy using Hybrid cell-count software (Keyence, Osaka, Japan) to calculate fluorescence intensity per cell.
+ Open protocol
+ Expand
3

Immunofluorescence Staining of Tendon Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescence staining, tendon cells were treated with lidocaine for 24 h and then fixed in 10% formalin for 15 min. The cells were washed in PBS three times and incubated in blocking solution (Thermo Fisher Scientific, Waltham, MA, USA) for 30 min. Subsequently, they were incubated for 2 h with an anti-tubulin antibody (Thermo Fisher Scientific, Waltham, MA, USA) diluted in blocking solution. The signal was detected using anti-mouse immunoglobulin (IgG) Alexa Fluor 488 (Thermo Fisher Scientific, Waltham, MA, USA). After being washed with PBS, the cells were mounted with mounting buffer containing 4′,6-diamidino-2-phenylindole (Abcam, Cambridge, MA, USA). The cells were observed under a fluorescence microscope at 200× magnification (Eclipse Ni-U; Nikon, Tokyo, Japan). The mitotic index was defined as the number of nuclei undergoing mitosis divided by the number of all cells on the coverslip and then multiplied by 100%.
+ Open protocol
+ Expand
4

Quantifying Neurogenesis via BrdU Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU (50 mg/kg; Sigma) in saline was given i.p. two times daily at 8-hr intervals on consecutive days (days 1–3 after PQ or saline administration). Mice were sacrificed on day 14 after the last injection. Brains were removed following 4% paraformaldehyde in PBS. Adjacent 50-μm sections were cut and stored at −80°C. BrdU detection was performed as described previously (Peng et al., 2008 (link)). Briefly, sections were incubated with 2 μg/mL mouse monoclonal anti-BrdU antibody (1:200, Roche) at 4°C overnight, washed with PBS, incubated with Alexa 488 anti-mouse secondary antibody (1:250) in blocking solution (Life Technologies) for 1 hr, and then washed and mounted on gelatin-coated slides with Fluoromount. SVZ BrdU+ cells were counted blinded in five 50-μm coronal sections per mouse spaced 200 μm apart under high power (200×) using a Nikon E300 microscope with a Magnifire digital camera. Results are expressed as the average number of BrdU+ cells per section.
+ Open protocol
+ Expand
5

Immunohistochemistry Protocol for Paraffin-Embedded Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the immunohistochemistry analysis, paraffin-embedded slides were deparaffinized in toluene and rehydrated in graded alcohol series (70, 80, 90, 95, and 100%) and distilled water. After rehydration, antigen retrieval was performed in a solution of 3% hydrogen peroxide in methanol solution at room temperature (25 °C) for 35 min and steamed for 30 min in 10 mmol/L citrate buffer for heat-induced antigen retrieval. After retrieval, the slides were cooled at room temperature for 2 h and were incubated first with a blocking solution (Life Technologies, Frederick, MD, USA) at room temperature for 1 h, then the sections were incubated with the primary antibody overnight at 4 °C. After incubation, the sections were washed in phosphate buffered saline (PBS), and the sections were incubated with a broad-spectrum secondary antibody and streptavidin-horseradish peroxidase conjugate (Life Technologies, Frederick, MD, USA) at room temperature for 10 min. The antigen-antibody complex was visualized with a diaminobenzidine (DAB) (Vector Laboratories, Burlingame, CA, USA). The sections were counterstained with 10% hematoxylin for 2 min and were dehydrated with an alcohol series and toluene.
+ Open protocol
+ Expand
6

Quantifying Neurogenesis via BrdU Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU (50 mg/kg; Sigma) in saline was given i.p. two times daily at 8-hr intervals on consecutive days (days 1–3 after PQ or saline administration). Mice were sacrificed on day 14 after the last injection. Brains were removed following 4% paraformaldehyde in PBS. Adjacent 50-μm sections were cut and stored at −80°C. BrdU detection was performed as described previously (Peng et al., 2008 (link)). Briefly, sections were incubated with 2 μg/mL mouse monoclonal anti-BrdU antibody (1:200, Roche) at 4°C overnight, washed with PBS, incubated with Alexa 488 anti-mouse secondary antibody (1:250) in blocking solution (Life Technologies) for 1 hr, and then washed and mounted on gelatin-coated slides with Fluoromount. SVZ BrdU+ cells were counted blinded in five 50-μm coronal sections per mouse spaced 200 μm apart under high power (200×) using a Nikon E300 microscope with a Magnifire digital camera. Results are expressed as the average number of BrdU+ cells per section.
+ Open protocol
+ Expand
7

Immunofluorescence Staining of Ninj1 and F4/80 in Colon Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescence assessment, colon sections were deparaffinized, hydrated with distilled water, and incubated in a blocking solution (Life Technologies, MD, USA) for 1 h at room temperature (RT). The primary antibody against Ninj1 (Abclon) was diluted 1:300 and applied to the section-containing slides at RT for 1 h. The bound primary antibodies were detected using 1:300 AlexaFluore568. To assess co-localization of Ninj1 and F4/80, 1:500 rat F4/80-FITC (eBioscience, CA, USA), was incubated with the slides, overnight at 4 °C, followed by staining with Ninj1 antibodies. The nucleus was stained, and the slides were mounted with Vectashield mounting medium (Vector Laboratories, CA, USA).
+ Open protocol
+ Expand
8

Western Blot Analysis of IDO1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell and/or tissue lysates were mixed with LDS sample buffer (4×) (Life Technologies, Carlsbad, CA) and sample reducing agent (10×) (Life Technologies). Samples were then denatured at 70 °C for 10 min. Equal amounts of total protein (25 µg/well) were loaded onto 10% Bis-Tris SDS-PAGE gels (Life Technologies) and resolved at 120 V for approximately 75 min. Proteins were transferred to a nitrocellulose membrane (Life Technologies) and nonspecific binding sites blocked for 30 min with blocking solution (Life Technologies). After blocking, the membranes were incubated by the anti-IDO1 antibody9 (link) (1 μg/mL) mixed together with an anti-GAPDH antibody (Novus Biologicals; 50 ng/mL) on a shaker overnight at 4 °C. Membranes were washed with wash solution (Life Technologies) and incubated with the appropriate secondary antibody solution conjugated with horseradish peroxidase (Life Technologies). After washing, membranes were visualized using an enhanced chemiluminescent imaging system (Life Technologies).
+ Open protocol
+ Expand
9

Immunostaining of Psoriasis Skin Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The present study was approved by the Institutional Review Board (IRB) of Okayama University Hospital (No. 1712-018). Extracutaneous biopsy specimens obtained from psoriasis patients for diagnostic use were subjected to immunostaining. Normal skin samples were obtained from healthy volunteers at Okayama University Hospital. Written informed consent was obtained from all tissue donors according to the Helsinki Declaration. Formalin-fixed, paraffin-embedded skin samples were cut into 4 µm sections and mounted on glass slides. The slides were deparaffinized and activated with citric acid buffer (0.01 mol/L, pH 6.0; LSI Medience Corporation, Tokyo, Japan) for 5 min at 90 °C in a pressure cooker. They were then incubated with peroxidase-blocking solutions (Dako, Glostrup, Copenhagen, Denmark) for 10 min at room temperature and blocking solution (Life Technologies, Carlsbad, CA, USA) at 4 °C overnight. Next, the sections were incubated with rabbit polyclonal anti-human IL-23Ap19 antibody (MBS240347; MyBio Source, San Diego, CA, USA) or mouse monoclonal anti-human IL-27/IL-35 EBI3 antibody (MAB6456; R&D Systems, Minneapolis, MN, USA) at 4 °C overnight. Finally, the slides were incubated with goat anti-mouse/rabbit IgG antibodies conjugated to peroxidase-labeled polymer (Dako, Tokyo, Japan) for 30 min. Histochemical visualization was carried out with 3,3-diaminobenzidine (DAB) (Dako).
+ Open protocol
+ Expand
10

Immunohistochemistry Protocol for MPO Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed as previously described [20 ]. Antigen retrieval was performed in 3% hydrogen peroxide diluted in methanol, followed by steaming in citric acid buffer. After cooling down for 2 h at RT, the slides were cleansed in distilled water and PBS before incubating in blocking solution (Life Technologies, Frederick, MD, USA). After blocking, the slides were adapted to primary antibody including anti-MPO (PA5-16672; Thermo Fisher Scientific, Waltham, MA, USA). After overnight incubation, the sections were rinsed three times in PBS and incubated with a secondary antibody and streptavidin-HRP (Life Technologies, Frederick, MD, USA). Then, the slides were visualized by diaminobenzidine (DAB) (Vector Laboratories, Burlingame, CA, USA) and 10% hematoxylin was used for counterstaining.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!